Arms race in NL West: Dodgers add Thome, Garland; Rockies get Contreras

Leave a comment

The Brad Penny pickup set off a chain reaction in the NL West, as the two remaining contenders also picked up pieces before the Monday night deadline to have new acquisitions qualify for postseason play.
The Dodgers landed a potential Hall of Famer in Jim Thome, but right-hander Jon Garland may well prove to be the bigger pickup. That’s because even if the Dodgers were willing to sacrifice defense at first base, Thome just isn’t much more than an emergency option in the field at this point of his career. He’ll be used strictly off the bench for his fourth major league team, at least until the World Series. He’s hit .206/.354/.365 in 63 at-bats as a pinch-hitter in his career. Over the last two years, he’s 1-for-15.
Garland is the second addition to the Dodger rotation in as many weeks, joining Vicente Padilla. He struggled in his first two months in the NL, but he’s amassed a 3.56 ERA in 16 starts since the beginning of June. Also encouraging is his 50/15 K/BB ratio in 78 1/3 innings over the last two months. He figures to replace Charlie Haeger for now, putting him in the rotation alongside Chad Billingsley, Clayton Kershaw and Randy Wolf. If Hiroki Kuroda can return in a week or two as hoped, then Padilla would likely head to the pen.
The Rockies also wanted Garland, but settled for Jose Contreras, who was 5-13 with a 5.42 ERA in 114 2/3 innings for the White Sox. Surprisingly, they’re sending back a decent prospect in Brandon Hynick, who was thought to be a possibility to take over as their new fifth starter. Hynick has a below average fastball, but his splitter is a nice pitch and he displays very good command. He might take over the fifth spot in the White Sox rotation. Contreras will try to help replace the injured Aaron Cook in Colorado. He seems to be on his last legs, but the league switch might do him some good.
Along with acquiring Hynick, the White Sox picked up infielder Justin Fuller for Thome. A 2006 11th-round pick, Fuller has hit .254/.340/.418 in 177 at-bats for high-A Inland Empire this year. He has a quality glove and he bats left-handed, so if he starts to show some offensive ability, he’ll get looks as a utilityman. He’s a long shot, though. With Thome gone, they’ll likely give Josh Fields significant time at DH in September. It could be his last chance with the club.

Pirates expressing interest in Justin Masterson

Justin Masterson
AP Photo/Ben Margot
Leave a comment

Pirates pitching coach Ray Searage has become the king of the reclamation project. And it sounds like he’s about to take on another big one …

Travis Sawchik of the Pittsburgh Tribune-Review reports that the Pirates have expressed interest in free agent Justin Masterson. The expectation is that it will be a one-year deal with the goal of rebuilding the right-hander’s value in an environment where many other struggling veteran pitchers have executed significant career turnarounds.

Masterson earned his first (and only) All-Star nod in 2013 when he registered a 3.45 ERA, 195 strikeouts, and three shutouts in 32 appearances with the Indians. But he had a 5.88 ERA in 128 2/3 innings between Cleveland and St. Louis in 2014 and he continued struggling to the tune of a 5.61 ERA with the Red Sox in 2015.

It’s not clear whether the Bucs would try him as a starter or reliever.

Zack Greinke deal “could come soon,” Dodgers and Giants lead the bidding

Zack Greinke
AP Photo/Mark J. Terrill

Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Tuesday for seven years, $217 million.

Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …

FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.

ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.

Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.

The Red Sox get their ace! Boston signs David Price to a 7-year, $217 million deal


Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.

This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.

Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.

The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.

Major League Baseball’s annual drug testing report has been released

Leave a comment

MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.

The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:

  • Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
  • 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
  • The previous year there were 7,929 total tests with 12 which resulted in discipline;
  • There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.

A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.

As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.